EUVIMEDEUVIMED entdecken
CrossrefInfokarte

CHST3 Skeletal Dysplasia and GRIA3 Neurodevelopmental Disorder: A Dual Diagnosis With a Recurrent Syrian CHST3 Variant

Bita Hashemi, Esther Abena Frimpomaah Nkrumah

Case Reports in Genetics · 2026-01 · 2026 (1)

DOI: 10.1155/crig/5154048 ↗
AbstractBibliografische Angaben

Abstract

CHST3 ‐related skeletal dysplasia is a rare autosomal recessive skeletal disorder characterized by disproportionate short stature, progressive skeletal abnormalities, and congenital joint dislocations, typically with preserved cognitive function. We report a Syrian boy presenting with severe skeletal dysplasia, epilepsy, profound developmental delay, and intellectual disability. Clinical evaluation and trio exome sequencing identified a homozygous recurrent pathogenic variant in CHST3 and a de novo likely pathogenic splice‐site variant in GRIA3 . The skeletal manifestations, including the pattern of dysplasia, were consistent with CHST3 ‐related disease. However, the severity of the neurodevelopmental phenotype and epilepsy were not explained by CHST3 deficiency alone and were more consistent with a GRIA3 ‐related neurodevelopmental disorder. This case illustrates the importance of considering dual molecular diagnoses when a patient’s phenotype extends beyond the expected clinical spectrum of a known genetic condition. Furthermore, it provides additional evidence supporting the pathogenicity of a recurrent CHST3 variant observed in individuals of Syrian ancestry, suggesting a possible founder effect. Recognition of blended phenotypes resulting from multiple genetic diagnoses is essential to avoid inappropriate expansion of disease phenotypes and to ensure accurate genetic counseling and clinical management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →